Antiviral use in liver function abnormalities and Covid-19 patients: Serial cases.

ABSTRACT:

Introduction

Some SARS-CoV-2 patients have liver function abnormalities due to anti-viral drug effects.

Methods

The design of this study was a case series reported using retrospectives. Data collection was carried out from December 2020 to February 2021. All participants were diagnosed with SAR-CoV-2 and received an anti-viral drug which identified liver function abnormalities.

Results

The patients' average age was 54.56 ± 14.46 years old. Most patients experienced shortness of breath and cough, with hypertension as the accompanying comorbid. Increased AST and ALT were found in one patient who used Lopinavir-Ritonavir. The increase was 1.0 times to 2.0 times the expected value. Increased CRP, D-dimer and procalcitonin were also found, with a mean of 12.27 ± 15,34, 186

SUBMITTER: Dewi IR 

PROVIDER: S-EPMC9652095 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature